Prevalence, persistence and liver enzyme levels of HGV RNA-positive blood donors determined by large-scale screening and transmission by blood components

Clinical Laboratory

Volumn 50, Issue 1-2, 2004, Pages 25-31

  Hitzler, Walter E ^a   Runkel, St ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Blood donors; HGV; Liver enzymes; Persistence, PCR; Prevalence; Transmission

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS ANTIBODY; HEPATITIS ANTIGEN; LIVER ENZYME; VIRUS RNA;

ADULT; ARTICLE; BLOOD COMPONENT; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS G; HEPATITIS G VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PERSISTENT VIRUS INFECTION; POSTTRANSFUSION HEPATITIS; PREVALENCE; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING TEST; SEROCONVERSION; VIREMIA; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BLOOD COMPONENT TRANSFUSION; BLOOD DONORS; FEMALE; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; RNA, VIRAL; VIREMIA;

GB VIRUS C/HEPATITIS G VIRUS; RNA VIRUSES;

EID: 1442305329     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Simons JN, Leary TP, Dawson GJ et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995a; 1:564-569
2. Leary, TP Muerhoff AS, Simons JN et al. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996;48: 60-67
3. Linnen J, Wages J, Zhang-Keek ZY et al. Molecular cloning and disease association of hepatitis G virus: a transfusion transmissible agent. Science 1996; 271:505-508
4. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1996;346: 1131-1132
5. Heringlake S Ockenga J, Tillmann HL, Trautwein HC, Meissner D, Stoll M, Hunt J, Jon C, Solomon N, Schmidt RE, Manns MP. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 1996;348: 1626-1629
6. Zaidi Y, Chapman CS, Myint S. Aplastic anaemia after HGV infection. Lancet 1996;348: 471-472
7. Byrnes JJ, Banks AT, Piatak M Jr, Kim JP. Hepatitis G-associated aplastic anaemia. Lancet 1996;348: 472
8. Kao J-H, Chen PJ, Chen DS. GBV-C in the aetiology of fulminant hepatitis. Lancet 1996;347: 120
9. Sallie R, Shaw J, Mutimer D. GBV-C virus and fulminant hepatic failure. Lancet 1996;347: 1552
10. Brown KE, Wong S, Young NS. Prevalence of GBV-C/HGV, a novel 'hepatitis' virus, in patients with aplastic anaemia. Br J Haematol 1997;97: 492-496
11. Lefrére JJ, Roudot-Thoraval F, Morand-Joubert L et al. Prevalence of GB virus type C/hepatitis G virus RNA and of anti-E" in individuals at high or low risk for blood-borne or sexually transmitted viruses: evidence of sexual and parenteral transmission. Transfusion 1999:39: 83-94
12. Thomas HC. Clinical significance of HGV. American Association for the Study of Liver diseases. International Symposium 'Hepatitis G Virus (HGV): a newly discovered hepatitis virus', Chicago 1995
13. Mercier B, Barclais A, Botte C et al. Prevalence of GBV-C/HGV RNA and GBV-C/HGV antibodies in French volunteer blood donors: results of a collaborative study, Vox Sang 1999; 76: 166-169
14. Tagger A. et al. Detection of GB virus C sequences in Italian blood donors and patients and in African individuals, IX. 1996 Triennial International Symposium on Viral Hepatitis and Liver Disease, Rome
15. Roth WK, Waschk D, Marx S et al. Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients. Transfusion 1997;37:651-656
16. Feucht HH, Zollner B, Polywka S et al. Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients. Hepatology 1997; 26:491-494
17. Alter MJ, Gallagher M, Morris TT et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 1997;336: 741-746
18. Alter HJ, Naktasuij Y, Melpolder J et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997;336: 747-754
19. Sathar M, Soni P, York D. GB virus C/hepatitis G virus (GBV-C/HGV): still looking for disease. Int J Exp Pathol 2000;81: 305-322